MedTrace Logo

The Effect of a Four-Week Hatha Yoga Intervention to Improve Quality of Life, Anxiety, and Depressive Symptoms in Individuals Undergoing Assisted Reproductive Technology (ART) Treatment

NCT07415850 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-02-17

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a four-week yoga program works to improve quality of life in people undergoing IVF (In Vitro Fertilization). It will also learn if a four-week yoga program decreases anxiety and depression symptoms in people undergoing IVF.

The main questions it aims to answer are:

* Does a four-week yoga program effect quality of life, anxiety, and depression symptoms in people undergoing IVF?
* Do the effects vary by individual characteristics of the people in the study?

Researchers will compare the yoga intervention group to routine care as usual.

Participants will:

* Participate in a weekly virtual yoga class for four weeks (total of four yoga classes), or follow routine care as usual while undergoing IVF.
* Take three online surveys every 4 weeks.
* Be involved in the study for 8 weeks.

Conditions

  • IVF
  • In Vitro Fertilization
  • Quality of Life (QOL)
  • Anxiety
  • Depression and Anxiety Symptom
  • Assisted Reproduction Technologies
  • Yoga
  • Mental Health

Interventions

BEHAVIORAL

Yoga

The intervention in this study is a four-week Hatha yoga intervention delivered virtually.

Sponsors & Collaborators

  • American Society for Reproductive Medicine

    collaborator UNKNOWN

  • Villanova University

    lead OTHER

Principal Investigators

  • Mary B Murray, MEd, BSN, RN · Villanova University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-21
Primary Completion
2026-12-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07415850 on ClinicalTrials.gov